Farther Finance Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Farther Finance Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$604	Hold	1,000	–	–	﹤0.01%	5711
2026 Q2	$739	Hold	1,000	–	–	﹤0.01%	5453
2026 Q1	$681	Hold	1,000	–	–	﹤0.01%	5208
2025 Q4	$712	Hold	1,000	–	–	﹤0.01%	4985
2025 Q3	$1.62K	Hold	1,000	–	–	﹤0.01%	4214
2025 Q2	$611	Buy	+1,000	New	+$509	﹤0.01%	4003

Other funds holding TNYA

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GGS

Galvin Gaustad & Stein Scottsdale, Arizona $1.33B AUM 13.15% 1-Year Est. Return

Farther Finance Advisors's TNYA Position: Q3 2026 in Review

Farther Finance Advisors held its Tenaya Therapeutics (TNYA) position steady in Q3 2026 at 1,000 shares worth $604. The position accounts for ﹤0.01% of the portfolio, ranked #5711.

Farther Finance Advisors first reported a position in TNYA in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.62K in Q3 2025. 4 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

Farther Finance Advisors held 1,000 shares of Tenaya Therapeutics worth $604 as of Q3 2026.
Farther Finance Advisors left its Tenaya Therapeutics share count unchanged in Q3 2026.
Tenaya Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5711 holding.
Farther Finance Advisors first reported a position in Tenaya Therapeutics in Q2 2025 and has held it in 6 quarters since.
Farther Finance Advisors's Tenaya Therapeutics position peaked at $1.62K in Q3 2025.
4 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.